Summary & Overview
CPT 88189: Flow Cytometry Interpretation, 16+ Markers
CPT code 88189 covers professional interpretation of flow cytometry studies that evaluate 16 or more markers, typically performed by a pathologist. This code captures a high-complexity diagnostic service used in hematopathology, immunology, and oncology workups where multi-parameter immunophenotyping informs diagnosis, staging, or treatment decisions. Nationally, use of high-parameter flow cytometry has increased as precision diagnostics expand, making accurate coding for interpretation essential for clinical documentation and payer adjudication.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of the clinical context for the code, typical sites of service, and the types of analyses that trigger use of this code. The publication also outlines common modifiers and payer considerations, expected service lines, and related coding items when available. Practical benchmarks and policy updates relevant to laboratory and pathology billing are summarized to help coding and revenue teams understand reimbursement landscapes and documentation expectations.
This summary is for a national audience and focuses on clinical and billing context rather than state-specific rules.
Billing Code Overview
CPT code 88189 describes the interpretation by a clinician, typically a pathologist, of flow cytometry results involving 16 or more markers. This is a professional interpretation service focused on complex immunophenotyping analyses.
-
Service type: Clinical pathology interpretation of advanced flow cytometry
-
Typical site of service: Clinical laboratory or pathology department within a hospital, reference laboratory, or outpatient diagnostic center
Data not available in the input for associated taxonomies and ICD-10 diagnoses.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with persistent lymphadenopathy and abnormal peripheral blood counts is referred for hematopathology workup. The clinician orders a comprehensive flow cytometry panel to evaluate for suspected hematologic malignancy (for example, lymphoma or leukemia). A specimen (peripheral blood, bone marrow aspirate, or lymph node fine needle aspiration) is collected in appropriate anticoagulant and sent to the pathology laboratory. A clinical laboratory technologist runs multicolor flow cytometry, assessing 16 or more markers to characterize cell lineage, immunophenotype, and clonality. A pathologist or board-certified clinical laboratory physician reviews histograms, dot plots, and gating strategies, integrates results with morphology and clinical history, and issues a signed interpretive report. Typical site of service is an outpatient pathology or hospital-based clinical laboratory; specimens may originate from inpatient wards, outpatient clinics, emergency departments, or ambulatory infusion centers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the interpreting professional component of the test |
TC | Technical component |